Communicating a Breast Cancer Diagnosis
Communicating a Breast Cancer Diagnosis: Introduction Print Section Listen The delivery of a diagnosis of breast cancer to a patient elicits a strong emotional response from the patient, and similarly,…
Breast Cancer Screening
Breast Cancer Screening: Introduction Print Section Listen Breast cancer is the most common malignancy affecting American women excluding skin cancers. It is the second leading cause of cancer-related deaths, having…
Initial AJCC Staging
Initial AJCC Staging: Introduction Print Section Listen Staging is the classification used to define the risk of cancer recurrence and mortality. Cancer staging is useful for assessing prognosis and defining…
Components of a Breast Care Program
Components of a Breast Care Program: Introduction Print Section Listen The last few decades have seen unprecedented advances in the screening, diagnosis, and treatment of patients with breast cancer. This…
Establishing a Cancer Genetics Service
Establishing a Cancer Genetics Service: Introduction Print Section Listen Given the accumulating evidence documenting the efficacy of genetic screening and risk-reduction interventions, genetic cancer risk assessment (GCRA) has become a…
Breast Carcinogenesis
Etiology, Assessing Risk, Initial Evaluation, and Management: Introduction Print Section Listen Breast cancer is an important health care problem since it is the most frequently occurring cancer (1 out of…
Polyclonal Polycythemias (Primary and Secondary)
INTRODUCTION Polycythemia, also referred to as erythrocytosis, is characterized by an increased red cell mass. There is no consensus on terminology (ie, primary familial polycythemia but postrenal transplantation erythrocytosis). Polycythemias…
Fragmentation Hemolytic Anemia
DEFINITION Acquired erythrocyte fragmentation occurs when red cells are forced at high shear stress through partial vascular occlusions or over abnormal vascular surfaces. In circumstances in which fragmentation of red…
Drug-Induced Hemolytic Anemia
ETIOLOGY AND PATHOGENESIS Three mechanisms of drug-related immunologic injury to red cells are defined: — Hapten/drug adsorption involving drug-dependent antibodies — Ternary complex formation involving drug-dependent antibodies — Induction of…
